Aviptadil acetate is an analog vasoactive intestinal polypeptide (VIP) with potent vasodilatory effects. Aviptadil acetate induces pulmonary vasodilation and inhibits vascular SMCs proliferation, platelet aggregation. Aviptadil acetate can be used for the research of pulmonary fibrosis, pulmonary arterial hypertension (PAH) and SARS-CoV-2 caused respiratory failure, et al.
性状
Solid
体外研究(In Vitro)
Aviptadil acetate (1 nM-10 μM) produces a concentration-dependent inhibition of CSE-induced cell death in L2 cells. At 10 μM, Aviptadil acetate reduces CSE-stimulated MMP activity and caspase-3 activation in L2 cells. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Sealed storage, away from moisture and lightPowder -80°C 2 years;-20°C 1 year
ClinicalTrial
SequenceShortening
HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
参考文献
[1]. Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (COVID-AIV)[2]. Jian Hu, et al. Novel Targets of Drug Treatment for Pulmonary Hypertension. Am J Cardiovasc Drugs
溶解度数据
In Vitro: H2O : 100 mg/mL (29.53 mM; Need ultrasonic)DMSO : 100 mg/mL (29.53 mM; Need ultrasonic)配制储备液